Literature DB >> 11511705

Serum concentration of adhesion molecules in patients with delayed ischaemic neurological deficit after aneurysmal subarachnoid haemorrhage: the immunoglobulin and selectin superfamilies.

J J Nissen1, D Mantle, B Gregson, A D Mendelow.   

Abstract

OBJECTIVES: Adhesion molecules are involved in the pathogenesis of cerebral ischaemia and may play a part in the pathophysiology of delayed ischaemic neurological deficit (DIND) after aneurysmal subarachnoid haemorrhage. It was hypothesised that after aneurysmal subarachnoid haemorrhage, adhesion molecules may play a part in the pathophysiology of DIND as reflected by significantly altered serum concentrations in patients with and without DIND.
METHODS: In a prospective study, mean serum concentrations of ICAM-1, VCAM-1, PECAM, and E, P, and L-selectin were compared between patients without (n=23) and with (n=13) DIND in patients with World Federation of Neurological Surgeons (WFNS) grades 1 or 2 subarachnoid haemorrhage. Serum was sampled from patients within 2 days of haemorrhage and on alternate days until discharge. Concentrations of adhesion molecules were measured by standard procedures using commercially available enzyme linked immunoabsorbent assays.
RESULTS: There were non-significant differences in serum concentrations of ICAM-1 (290.8 ng/ml v 238.4 ng/ml, p=0.0525), VCAM-1 (553.2 ng/ml v 425.8 ng/ml, p=0.053), and PECAM (22.0 ng/ml v 21.0 ng/ml, p=0.56) between patients without and with DIND respectively. The E-selectin concentration between the two patient groups (44.0 ng/ml v 37.4 ng/ml, p=0.33) was similar. The P-selectin concentration, however, was significantly higher in patients with DIND compared with those patients without DIND (149.5 ng/ml v 112.9 ng/ml, p=0.039). By contrast, serum L-selectin concentrations were significantly lower in patients with DIND (633.8 ng/ml v 897.9 ng/ml, p=0.013).
CONCLUSIONS: Of all the adhesion molecules examined in this study, P and L-selectin are involved in the pathophysiology of DIND after aneurysmal subarachnoid haemorrhage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511705      PMCID: PMC1737572          DOI: 10.1136/jnnp.71.3.329

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  40 in total

1.  THE PATHOGENESIS OF CEREBRAL INFARCTION FOLLOWING THE RUPTURE OF CEREBRAL BERRY ANEURYSMS.

Authors:  M R CROMPTON
Journal:  Brain       Date:  1964-09       Impact factor: 13.501

2.  Adrenaline upregulates monocyte L-selectin in vitro.

Authors:  T H Rainer; N Lam; R A Cocks
Journal:  Resuscitation       Date:  1999-12       Impact factor: 5.262

3.  The correlation between immunological reaction in the arterial wall and the time course of the development of cerebral vasospasm in a primate model.

Authors:  Y Handa; M Kabuto; H Kobayashi; H Kawano; H Takeuchi; M Hayashi
Journal:  Neurosurgery       Date:  1991-04       Impact factor: 4.654

4.  Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale.

Authors: 
Journal:  J Neurosurg       Date:  1988-06       Impact factor: 5.115

5.  Cerebral vasospasm and ultrastructural changes in cerebral arterial wall. An experimental study.

Authors:  Y Tanabe; K Sakata; H Yamada; T Ito; M Takada
Journal:  J Neurosurg       Date:  1978-08       Impact factor: 5.115

6.  Cerebral infarction and release of platelet thromboxane after subarachnoid hemorrhage.

Authors:  S Juvela
Journal:  Neurosurgery       Date:  1990-12       Impact factor: 4.654

7.  Imaging of leukocytic infiltration in human cerebral infarcts.

Authors:  C Pozzilli; G L Lenzi; C Argentino; A Carolei; M Rasura; A Signore; L Bozzao; P Pozzilli
Journal:  Stroke       Date:  1985 Mar-Apr       Impact factor: 7.914

8.  Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial.

Authors:  J D Pickard; G D Murray; R Illingworth; M D Shaw; G M Teasdale; P M Foy; P R Humphrey; D A Lang; R Nelson; P Richards
Journal:  BMJ       Date:  1989-03-11

9.  Endothelial cell expression of the intercellular adhesion molecule-1 (ICAM-1) in the central nervous system of guinea pigs during acute and chronic relapsing experimental allergic encephalomyelitis.

Authors:  C E Wilcox; A M Ward; A Evans; D Baker; R Rothlein; J L Turk
Journal:  J Neuroimmunol       Date:  1990-11       Impact factor: 3.478

10.  Platelet thromboxane release and delayed cerebral ischemia in patients with subarachnoid hemorrhage.

Authors:  S Juvela; M Hillbom; M Kaste
Journal:  J Neurosurg       Date:  1991-03       Impact factor: 5.115

View more
  15 in total

1.  Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome.

Authors:  C J M Frijns; R Fijnheer; A Algra; J A van Mourik; J van Gijn; G J E Rinkel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

2.  Delayed morbidity and mortality in aneurysmal subarachnoid hemorrhage patients: effect of attenuating cerebral vasospasm.

Authors:  Dale Ding
Journal:  Neurol Sci       Date:  2014-07-01       Impact factor: 3.307

Review 3.  Mechanisms of neuroinflammation and inflammatory mediators involved in brain injury following subarachnoid hemorrhage.

Authors:  Takeshi Okada; Hidenori Suzuki
Journal:  Histol Histopathol       Date:  2020-02-06       Impact factor: 2.303

4.  The changes of von willebrand factor/a disintegrin-like and metalloprotease with thrombospondin type I repeats-13 balance in aneurysmal subarachnoid hemorrhage.

Authors:  Qi-Feng Tang; Shi-Qi Lu; Yi-Ming Zhao; Jin-Xian Qian
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 5.  Brain ischemia in patients with intracranial hemorrhage: pathophysiological reasoning for aggressive diagnostic management.

Authors:  Daniel Naranjo; Michal Arkuszewski; Wojciech Rudzinski; Elias R Melhem; Jaroslaw Krejza
Journal:  Neuroradiol J       Date:  2013-12-18

6.  Endothelial cell activation markers and delayed cerebral ischaemia in patients with subarachnoid haemorrhage.

Authors:  C J M Frijns; K M Kasius; A Algra; R Fijnheer; G J E Rinkel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-30       Impact factor: 10.154

Review 7.  Adhesion molecules in CNS disorders: biomarker and therapeutic targets.

Authors:  Qingyi Ma; Sheng Chen; Damon Klebe; John H Zhang; Jiping Tang
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

8.  TNF-alpha and sICAM-1 in intracranial aneurismal rupture.

Authors:  Anna Maria Witkowska; Maria Halina Borawska; Katarzyna Socha; Jan Kochanowicz; Zenon Mariak; Maria Konopka
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-04-02       Impact factor: 4.291

Review 9.  The endothelium, a protagonist in the pathophysiology of critical illness: focus on cellular markers.

Authors:  Sabrina H van Ierssel; Philippe G Jorens; Emeline M Van Craenenbroeck; Viviane M Conraads
Journal:  Biomed Res Int       Date:  2014-04-01       Impact factor: 3.411

Review 10.  Therapeutic implications of estrogen for cerebral vasospasm and delayed cerebral ischemia induced by aneurysmal subarachnoid hemorrhage.

Authors:  Dale Ding; Robert M Starke; Aaron S Dumont; Gary K Owens; David M Hasan; Nohra Chalouhi; Ricky Medel; Chih-Lung Lin
Journal:  Biomed Res Int       Date:  2014-03-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.